ArticleFrontiers in oncology2025
Influencing factors on attendance in cervical cancer screening among women with diabetes in Hungary: a cross-sectional study using European Health Interview Surveys 2009-2019.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: With this study, we examined the participation in cervical cancer screening among women with diabetes and the influencing factors of attendance. Methods: Data from the European Health Interview Surveys in Hungary (2009, 2014, 2019) were analyzed with multivariate and multiple logistic regressions. Results: A higher level of education (OR=2.56, 95% CI: 1.03-6.33 in the case of secondary level in 2014; and OR=3.09, 95% CI: 1.17-8.13 in the case of tertiary level in 2019, OR= 2.24, 95% CI: 1.12-4.46 in the case of tertiary level in the pooled data), a perceived good economic situation (OR=2.31, 95% CI: 1.30-4.09 in the pooled data), participation in breast cancer screening (OR= 5.41, 95% CI: 3.49-8.38 in the pooled data), and social support (OR= 2.04 95% CI: 1.03-4.03 in 2019) have a positive effect on participation in screening. Taking prescription drugs (OR= 0.31 95% CI: 0.12-0.83, in the pooled data), lower economic status (OR=0.25 95% CI:0.07-0.88, in 2009) and worse perceived health (OR= 0.20, 95% CI: 0.06-0.64 in 2014) can be considered factors with a negative effect. Conclusion: This study identified groups with low participation rates and made it clear that those groups with unfavorable health factors (bad financial status, bad perceived health, taking prescription drugs) participate the least in screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.